Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @a_kaltenboeck
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @a_kaltenboeck
-
Prikvačeni tweet
Hi everyone - just published on value-based pricing in
@ASCPT_ClinPharm with@maura_calsyn@GeertFrederix@jilowenthal@DavidP4AD@BERector@AmeetSarpatwari cc@PORTAL_Research@peterbachmd
#tweetorial about VBP for drugs follows below
1/11pic.twitter.com/oWfct7TOlMPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
The President sent a clear signal to Senate leadership in support of
@ChuckGrassley's bill to stop drug corporation price gouging. Contrary to the President’s claim, Rx prices aren't coming down-they continue to rise. The House did its job w/H.R. 3. Now the Senate must act.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
I spoke in front of 3,000 Iowa Republicans last night. It was like a MAGA rally. I told them we needed a President who doesn’t lie all the time. The crowd booed me. I told them we needed a President who wasn’t indecent & cruel. The crowd booed me. 1/
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RT
@AssumeNormality Trends in access to care from 2011-2017. Super interesting readhttps://twitter.com/AssumeNormality/status/1224753074780000256 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
Opinion: If more people have health insurance, why is health care getting less affordable?https://buff.ly/38YPv7Y
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
I examined how the Top 4 Democratic candidates (current
@RealClearNews national standings) propose to reduce Prescription Drug Costs.@JoeBiden@SenSanders@ewarren@MikeBloomberg All great ideas. In bold font are the more unique proposals they emphasize.@ASlavitt@peterbachmdpic.twitter.com/TFnPvE2ftt
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
Don't forget: The FDA has long known that many expired medicines remain safe and potent for years longer.https://propub.li/36G1JAP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
Great thread on value-based pricing
#drugpricing (@a_kaltenboeck, it looks like you took@DusetzinaS’s class on tweeting with gifs
)https://twitter.com/a_kaltenboeck/status/1219421884737118208 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
“If you know that you can’t get $14,000 for your cancer drug that is garbage...then maybe that would help us get the right type of innovation.” -
@DusetzinaS, dishing out a full month’s supply of common sense on@chadinabhan’s Outspoken Oncology.@peterbachmd@a_kaltenboeckPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Check out
@DhruvKhullar and@peterbachmd@NEJM on relationship b/t policy & returns on innovation. The interactive tool alone is worth it!https://twitter.com/peterbachmd/status/1222646227088683008 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
This figure shows the alarming problem. The annual cost of specialty drugs is increasing dramatically. The falling costs of generics won’t save us.
@leighdrugwonk@policydeb@a_kaltenboeck@peterbachmd https://www.aarp.org/content/dam/aarp/ppi/2019/06/trends-in-retail-prices-of-specialty-prescription-drugs-year-end-update.doi.10.26419-2Fppi.00073.001.pdf …pic.twitter.com/ER1OTZxrct
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
A new analysis finds that patient groups funded by drug makers generally support corporate interests, few groups have policies governing industry backing, and transparency is often lacking.https://buff.ly/2vj12jX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
BREAKING: CDC reports second U.S. case of novel virus spreading in Chinahttps://buff.ly/2Rnh7xv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
another pricey cancer drug approved on super small trial with surrogate endpoint.https://twitter.com/NedPagliarulo/status/1220479058800189440 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
We share our strength when we share our stories. Here's mine. Together we can restore balance to ensure we get the innovative new drugs we need at prices we can afford.pic.twitter.com/sU4cUq7EJy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thought experiment: if we put and excise tax on these expenditures, what would happen, and what could we do with the money?https://twitter.com/statnews/status/1220405953130090497 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Interesting read for anyone interested in COI among industry-funded patient groups. US is not the only country with this concern
@DavidP4AD@benwakana@VincentRK@DKorensteinhttps://www.bmj.com/content/368/bmj.l6925 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
Some surprises in new report on
#PBMs in Maryland's#Medicaid program https://drugch.nl/2R8YLAz : 1. Spreads = $72M (+10.4%) over payments to#pharmacies 2. Net *increase* of 58 small/independent pharmacies (+15%) Both sides in#PBM vs.#pharmacy debate can claim some vindicationpic.twitter.com/vnFomEPJ0q
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
Civica Rx is teaming with the Blue Cross Blue Shield and 18 of its health plans to supply copycat medicines.https://buff.ly/2NNVTXy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
MedTweetorial:
#Tweetorial Author:@a_kaltenboeck Type:#EBM#policy Specialty:#IM Topics:#value_based_pricing#VBPhttps://twitter.com/a_kaltenboeck/status/1219421884737118208 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Anna Kaltenboeck proslijedio/la je Tweet
Financial Conflict of Interests in Medicine. Following discussion with
@chadinabhan here is a draft proposal. We don’t want everyone involved in clinical trials to be labeled as conflicted - coz if everyone is conflicted then no one is conflicted. Comments welcome.@VPrasadMDMPHpic.twitter.com/yIvvJXx13p
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
